Laura J Vella
Title
Cited by
Cited by
Year
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
18412018
Packaging of prions into exosomes is associated with a novel pathway of PrP processing
LJ Vella, RA Sharples, VA Lawson, CL Masters, R Cappai, AF Hill
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
3972007
EVpedia: a community web portal for extracellular vesicles research
DK Kim, J Lee, SR Kim, DS Choi, YJ Yoon, JH Kim, G Go, D Nhung, ...
Bioinformatics 31 (6), 933-939, 2015
2682015
Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes
RA Sharples, LJ Vella, RM Nisbet, R Naylor, K Perez, KJ Barnham, ...
The FASEB Journal 22 (5), 1469-1478, 2008
2152008
The role of exosomes in the processing of proteins associated with neurodegenerative diseases
LJ Vella, RA Sharples, RM Nisbet, R Cappai, AF Hill
European Biophysics Journal 37 (3), 323-332, 2008
2092008
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid
LJ Vella, DLV Greenwood, R Cappai, JPY Scheerlinck, AF Hill
Veterinary immunology and immunopathology 124 (3-4), 385-393, 2008
1922008
Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer’s and Parkinson’s disease
LJ Vella, AF Hill, L Cheng
International journal of molecular sciences 17 (2), 173, 2016
1192016
C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
J Meyerowitz, SJ Parker, LJ Vella, DCH Ng, KA Price, JR Liddell, ...
Molecular neurodegeneration 6 (1), 1-22, 2011
1072011
MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells
LJ Vella, A Pasam, N Dimopoulos, M Andrews, A Knights, AL Puaux, ...
Cancer immunology research 2 (4), 351-360, 2014
1042014
The emerging role of exosomes in epithelial–mesenchymal-transition in cancer
LJ Vella
Frontiers in oncology 4, 361, 2014
1002014
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
A Jayachandran, M Anaka, P Prithviraj, C Hudson, SJ McKeown, PH Lo, ...
Oncotarget 5 (14), 5782, 2014
862014
A rigorous method to enrich for exosomes from brain tissue
LJ Vella, BJ Scicluna, L Cheng, EG Bawden, CL Masters, CS Ang, ...
Journal of extracellular vesicles 6 (1), 1348885, 2017
802017
The contribution of tumour-derived exosomes to the hallmarks of cancer
K Meehan, LJ Vella
Critical reviews in clinical laboratory sciences 53 (2), 121-131, 2016
732016
Mouse-adapted sporadic human Creutzfeldt–Jakob disease prions propagate in cell culture
VA Lawson, LJ Vella, JD Stewart, RA Sharples, H Klemm, DM Machalek, ...
The international journal of biochemistry & cell biology 40 (12), 2793-2801, 2008
692008
BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.
MC Andrews, A Behren, F Chionh, J Mariadason, LJ Vella, H Do, ...
Journal of clinical oncology: official journal of the American Society of …, 2013
502013
PrP C-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site
CL Haigh, VA Lewis, LJ Vella, CL Masters, AF Hill, VA Lawson, SJ Collins
Cell research 19 (9), 1062-1078, 2009
452009
The Ludwig institute for cancer research Melbourne melanoma cell line panel
A Behren, M Anaka, PH Lo, LJ Vella, ID Davis, J Catimel, T Cardwell, ...
Pigment cell & melanoma research 26 (4), 597-600, 2013
372013
The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism
L Spoerri, LJ Vella, CLL Pham, KJ Barnham, R Cappai
Journal of Biological Chemistry 287 (32), 26840-26853, 2012
302012
Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments
LJ Vella, R Cappai
The FASEB Journal 26 (7), 2930-2940, 2012
292012
Phosphoproteomic analysis of cell-based resistance to BRAF inhibitor therapy in melanoma
R Parker, LJ Vella, D Xavier, A Amirkhani, J Parker, J Cebon, MP Molloy
Frontiers in oncology 5, 95, 2015
212015
The system can't perform the operation now. Try again later.
Articles 1–20